Step up regulation: On AYUSH medical education

The rapid expansion of AYUSH education, heavily reliant on private institutions, exposes significant governance deficits in medical education regulation. The profit motive often drives private entities to maximize student intake without commensurate investments in faculty and infrastructure, a classic example of market failure requiring robust state intervention. The National Commission for Indian System of Medicine (NCISM) and the National Commission for Homoeopathy (NCH), established to replace the corruption-plagued Central Council of Indian Medicine and Central Council of Homoeopathy, respectively, must demonstrate effective regulatory capacity. Their actions, such as withholding permissions for non-compliance, indicate a functioning system, but the sheer volume of low-graded institutions highlights the need for a shift from mere punitive action to systemic reform. This scenario underscores the challenges in ensuring quality assurance in professional education, a critical component of SDG 3 (Good Health and Well-being) and SDG 4 (Quality Education). UPSC candidates should analyze the efficacy of these regulatory bodies and suggest measures to enhance accountability, transparency, and standard-setting in alternative medical education.

The quality of AYUSH education directly impacts public health outcomes, particularly in rural and underserved areas where alternative medicine practitioners often serve as the primary point of care. If institutions churn out graduates with inadequate training and exposure to evidence-based practices, it compromises patient safety and undermines trust in the healthcare system. The historical legacy of quality issues, as documented by the Comptroller and Auditor General (CAG) in 2005, suggests that the current boom may be exacerbating systemic weaknesses. Furthermore, the integration of AYUSH practitioners into mainstream healthcare delivery, such as under the National Health Mission (NHM), necessitates rigorous training standards to ensure they complement rather than compromise care. This raises broader questions about health equity and the state's responsibility to provide standard, quality healthcare to all citizens. The debate extends to the need for strengthening the evidence base of AYUSH medicinal systems, ensuring that traditional knowledge is validated by rigorous scientific inquiry before widespread integration into public health programs.

The regulation of medical education falls under the Concurrent List (Entry 25) of the Seventh Schedule, giving both the Centre and states legislative authority. However, the Centre exercises predominant control through statutory bodies like the NCISM and NCH, reflecting a trend of centralization in higher education regulation. The reliance on centralized bodies for standard-setting, while ensuring uniformity, often struggles with enforcement at the state level, where local dynamics and political economy influence institutional operations. The AYURGYAN Scheme, a Central Sector Scheme, exemplifies the Union government's financial muscle in driving policy priorities in health education. The persistent non-compliance by private institutions, despite regulatory frameworks, highlights the tension between profit-driven education models and welfare-oriented regulatory mandates. For UPSC Mains, this scenario serves as a case study in analyzing the challenges of regulating quasi-public goods (like medical education) in a federal structure and the necessity of aligning financial incentives with quality outcomes.